NCT07554924: A Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type I
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 11 planned
- Started
- 15 Jul 2026
- Primary completion
- 25 May 2029
- Arms
- Dose-escalation
- Results
- None posted
- 28 Apr 2026: Trial registered
- 15 Jul 2026: Trial started